Biblio

Export 1937 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is B  [Clear All Filters]
2022
A. A. Diaz Baquero, Franco-Martín, M. A., Vidales, E. Parra, Toribio-Guzmán, J. Miguel, Bueno-Aguado, Y., Abad, F. Martínez, Bartolomé, M. V. Perea, Asl, A. Mahmoudi, and van der Roest, H. G., The Effectiveness of GRADIOR: A Neuropsychological Rehabilitation Program for People with Mild Cognitive Impairment and Mild Dementia. Results of a Randomized Controlled Trial After 4 and 12 Months of Treatment., J Alzheimers Dis, vol. 86, no. 2, pp. 711-727, 2022.
H. Macpherson, Brownell, S., Harris, E., Duckham, R. L., O'Connell, S., Meyer, B. J., Mirzaee, S., and Daly, R. M., Effects of a 6-Month Multifaceted Diet and Exercise Intervention on Cognition in Older Adults at Risk of Cognitive Decline: The PONDER Double-Blind, Placebo-Controlled Randomized Trial., J Alzheimers Dis, vol. 89, no. 1, pp. 247-263, 2022.
E. Howard, Ballinger, S., Kinney, N. G., Balgenorth, Y., Ehrhardt, A., Phillips, J. S., Irwin, D. J., Grossman, M., and Cousins, K. A. Q., Frontal Atrophy and Executive Dysfunction Relate to Complex Numbers Impairment in Progressive Supranuclear Palsy., J Alzheimers Dis, vol. 88, no. 4, pp. 1553-1566, 2022.
E. Howard, Ballinger, S., Kinney, N. G., Balgenorth, Y., Ehrhardt, A., Phillips, J. S., Irwin, D. J., Grossman, M., and Cousins, K. A. Q., Frontal Atrophy and Executive Dysfunction Relate to Complex Numbers Impairment in Progressive Supranuclear Palsy., J Alzheimers Dis, vol. 88, no. 4, pp. 1553-1566, 2022.
M. Gentreau, Reynes, C., Sabatier, R., Maller, J. J., Meslin, C., Deverdun, J., Le Bars, E., Raymond, M., Berticat, C., and Artero, S., Glucometabolic Changes Are Associated with Structural Gray Matter Alterations in Prodromal Dementia., J Alzheimers Dis, vol. 89, no. 4, pp. 1293-1302, 2022.
L. Clare, Martyr, A., Gamble, L. D., Pentecost, C., Collins, R., Dawson, E., Hunt, A., Parker, S., Allan, L., Burns, A., Hillman, A., Litherland, R., Quinn, C., Matthews, F. E., and Victor, C., Impact of COVID-19 on 'Living Well' with Mild-to-Moderate Dementia in the Community: Findings from the IDEAL Cohort., J Alzheimers Dis, vol. 85, no. 2, pp. 925-940, 2022.
J. I. Broussard, Redell, J. B., Maynard, M. E., Zhao, J., Moore, A., Mills, R. W., Hood, K. N., Underwood, E., Roysam, B., and Dash, P. K., Impaired Experience-Dependent Refinement of Place Cells in a Rat Model of Alzheimer's Disease., J Alzheimers Dis, vol. 86, no. 4, pp. 1907-1916, 2022.
C. M. Hoffmann, Nianogo, R. A., Yaffe, K., Rosenwohl-Mack, A., Carrasco, A., and Barnes, D. E., Importance of Accounting for Regional Differences in Modifiable Risk Factors for Alzheimer's Disease and Related Dementias: The Case for Tailored Interventions., J Alzheimers Dis, vol. 89, no. 2, pp. 563-570, 2022.
J. Laton, Van Schependom, J., Goossens, J., Wiels, W., Sieben, A., De Deyn, P. Paul, Goeman, J., Streffer, J., van der Zee, J., Martin, J. - J., Van Broeckhoven, C., De Vos, M., Bjerke, M., Nagels, G., and Engelborghs, S., Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study., J Alzheimers Dis, vol. 90, no. 4, pp. 1739-1747, 2022.
S. Cascini, Agabiti, N., Marino, C., Acampora, A., Balducci, M., Calandrini, E., Davoli, M., and Bargagli, A. Maria, Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study., J Alzheimers Dis, vol. 89, no. 2, pp. 681-693, 2022.
S. Cascini, Agabiti, N., Marino, C., Acampora, A., Balducci, M., Calandrini, E., Davoli, M., and Bargagli, A. Maria, Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study., J Alzheimers Dis, vol. 89, no. 2, pp. 681-693, 2022.
Z. D. Green, Vidoni, E. D., Swerdlow, R. H., Burns, J. M., Morris, J. K., and Honea, R. A., Increased Functional Connectivity of the Precuneus in Individuals with a Family History of Alzheimer's Disease., J Alzheimers Dis, vol. 91, no. 2, pp. 559-571, 2022.
K. Wittfeld, Raman, M. R., Conner, S. C., Aslam, A., Teumer, A., Nauck, M., Hosten, N., Habes, M., DeCarli, C., Vasan, R. S., Beiser, A. S., Himali, J. J., Seshadri, S., Grabe, H. J., and Satizabal, C. L., Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults., J Alzheimers Dis, vol. 88, no. 1, pp. 311-32, 2022.
M. Assogna, Motta, C., Bonní, S., Borghi, I., Casula, E. P., Martorana, A., and Koch, G., Isolated Amyloid-β Pathology Is Associated with Preserved Cortical Plasticity in APOE4 Alzheimer's Disease Patients., J Alzheimers Dis, vol. 86, no. 2, pp. 773-778, 2022.
M. Assogna, Motta, C., Bonní, S., Borghi, I., Casula, E. P., Martorana, A., and Koch, G., Isolated Amyloid-β Pathology Is Associated with Preserved Cortical Plasticity in APOE4 Alzheimer's Disease Patients., J Alzheimers Dis, vol. 86, no. 2, pp. 773-778, 2022.
K. K. Bawa, Ba, J., Kiss, A., Wang, R. D., Feng, V., Swardfager, W., Andreazza, A., Gallagher, D., Marotta, G., Herrmann, N., and Lanctôt, K. L., Lipid Peroxidation as a Marker of Apathy and Executive Dysfunction in Patients at Risk for Vascular Cognitive Impairment., J Alzheimers Dis, vol. 89, no. 2, pp. 733-743, 2022.
K. K. Bawa, Ba, J., Kiss, A., Wang, R. D., Feng, V., Swardfager, W., Andreazza, A., Gallagher, D., Marotta, G., Herrmann, N., and Lanctôt, K. L., Lipid Peroxidation as a Marker of Apathy and Executive Dysfunction in Patients at Risk for Vascular Cognitive Impairment., J Alzheimers Dis, vol. 89, no. 2, pp. 733-743, 2022.
I. Beheshti, Geddert, N., Perron, J., Gupta, V., Albensi, B. C., and Ko, J. Hyun, Monitoring Alzheimer's Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods., J Alzheimers Dis, vol. 89, no. 4, pp. 1493-150, 2022.
G. Weinstein, O'Donnell, A., Davis-Plourde, K., Zelber-Sagi, S., Ghosh, S., DeCarli, C. S., Thibault, E. G., Sperling, R. A., Johnson, K. A., Beiser, A. S., and Seshadri, S., Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study., J Alzheimers Dis, vol. 86, no. 3, pp. 1371-1383, 2022.
M. Pejstrup Agger, Carstensen, M. Schultz, Henney, M. Alexander, Hansen, L. Skytte, Baandrup, A. Ohlhues, Nguyen, M., Petersen, P. Michael, Madsen, K. Hougaard, and Kjær, T. Wesenberg, Novel Invisible Spectral Flicker Induces 40 Hz Neural Entrainment with Similar Spatial Distribution as 40 Hz Stroboscopic Light., J Alzheimers Dis, vol. 88, no. 1, pp. 335-344, 2022.
V. Panzarella, Mauceri, R., Baschi, R., Maniscalco, L., Campisi, G., and Monastero, R., Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabút Aging Project., J Alzheimers Dis, vol. 87, no. 1, pp. 173-183, 2022.
A. Bittar, Al-Lahham, R., Bhatt, N., Moore, K., Montalbano, M., Jerez, C., Fung, L., McAllen, S., Ellsworth, A., and Kayed, R., Passive Immunotherapy Targeting Tau Oligomeric Strains Reverses Tauopathy Phenotypes in Aged Human-Tau Mice in a Mouse Model-Specific Manner., J Alzheimers Dis, vol. 90, no. 3, pp. 1103-1122, 2022.
A. Bittar, Al-Lahham, R., Bhatt, N., Moore, K., Montalbano, M., Jerez, C., Fung, L., McAllen, S., Ellsworth, A., and Kayed, R., Passive Immunotherapy Targeting Tau Oligomeric Strains Reverses Tauopathy Phenotypes in Aged Human-Tau Mice in a Mouse Model-Specific Manner., J Alzheimers Dis, vol. 90, no. 3, pp. 1103-1122, 2022.
P. Agarwal, Holland, T. M., James, B. D., Cherian, L. J., Aggarwal, N. T., Leurgans, S. E., Bennett, D. A., and Schneider, J. A., Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study., J Alzheimers Dis, vol. 88, no. 2, pp. 653-661, 2022.
B. Rippon, Palta, P., Tahmi, M., Sherwood, G., Soto, L., Cespedes, S., Mesen, Y., He, H., Laing, K., Moreno, H., Teresi, J., Razlighi, Q., Brickman, A. M., Zetterberg, H., and Luchsinger, J. A., Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics., J Alzheimers Dis, vol. 87, no. 3, pp. 1229-1238, 2022.

Pages